Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell Endeavor BioMedicines Stock

Endeavor BioMedicines Stock

endeavorbiomedicines.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $295.58MM

Endeavor BioMedicines is a biotechnology company that is striving to discover new ways to treat patients who have life-threatening diseases. The company is working toward that goal by aiming to combat the drivers of fibrosis and oncology, which are both areas of medicine that have unmet needs. Endeavor BioMedicines was founded in 2018 by John Hood and Miguel de los Rios and is headquartered in San Diego, CA. In addition to looking for treatments that alleviate symptoms, Endeavor BioMedicines is seeking ways to reverse the effects of terminal illnesses.

Buy or sell Endeavor BioMedicines stockLearn more about Endeavor BioMedicines IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Endeavor BioMedicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Endeavor BioMedicines’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Endeavor BioMedicines.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Endeavor BioMedicines investors also invested in these private companies

Fidelity Management & Research
T. Rowe Price
Longitude Capital
Perceptive Advisors
Woodline Partners
The Invus Group
Ally Bridge Group
Avidity Partners
Piper Sandler
SymBiosis Capital Management
Revelation Partners
CE-Ventures
Omega Funds
Matrix Capital Management
Abrdn
Eckuity
Silver Arch Bio
Velosity Capital

Team

Management Team

John Hood Ph.D
Co-Founder & Chief Executive Officer
Miguel de los Rios Ph.D
Co-Founder, President & Chief Scientific Officer
Vishaal Turakhia
Chief Financial Officer
Chris Krueger
Chief Operating Officer
Paul Frohna MD
Chief Medical Officer
Enoch Kariuki
President

Board Members

Andrew Lam
Ally Bridge Group
Bernard Davitian
Omega Funds
Brian Liu MD
Longitude Capital
Cindy Wang Ph.D
Longitude Capital
Karan Takhar
Matrix Capital Management
Monal Mehta Ph.D
Avidity Partners
Noelle Hutchins Ph.D
Omega Funds
Otello Stampacchia Ph.D
Omega Funds
Patrick Enright
Longitude Capital

Endeavor BioMedicines stock FAQs

plusminus

Can you buy Endeavor BioMedicines stock?

As Endeavor BioMedicines is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Endeavor BioMedicines, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Endeavor BioMedicines stock?

To invest in a private company like Endeavor BioMedicines through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Endeavor BioMedicines stock?

Yes, you may be able to sell your Endeavor BioMedicines stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Endeavor BioMedicines stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Endeavor BioMedicines stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Endeavor BioMedicines a public company?

No, Endeavor BioMedicines is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Endeavor BioMedicines’ stock price?

Endeavor BioMedicines is a privately held company and therefore does not have a public stock price. However, you may access Endeavor BioMedicines’ private market stock price with Forge Data.
plusminus

What is Endeavor BioMedicines’ stock ticker symbol?

Endeavor BioMedicines does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Endeavor BioMedicines in the BioTech & Pharma sector

Colossal Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B
Altos Labs
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B
ADARx Pharmaceuticals
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM
Cytonics
Sector
Healthcare / BioTech & Pharma
 
 
AI Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM
Egenesis
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$333.77MM
Apnimed
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$366.58MM
Pendulum Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM
Element Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.05B
Fierce Biotech 04/24/2024

Endeavor bags $132.5M series C, extending runway for clinical-stage fibrosis drugs through 2026

In series C funding led by new investors such as AyurMaya, Endeavor raised $132.5 million.
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.